🌍 Exploring the Link Between Heart and Kidney Dysfunction in Type IV Cardiorenal Syndrome
Dr. Almammadov Fazil Choban
Director
Azerbaijan Medical University, Azerbaijan
Presentation Type: Oral Presentation (Virtual)
Title: Associations between cardiac
and renal biomarkers in patients with type iv cardiorenal syndrome
🫀 Understanding Type IV Cardiorenal Syndrome
Long-term kidney dysfunction can trigger several harmful processes in the body, including:
-
Persistent inflammation
-
Neurohormonal activation
-
Endothelial dysfunction
-
Anemia
-
Mineral metabolism disturbances
-
Progressive myocardial remodeling
These mechanisms collectively increase the risk of heart failure in patients with chronic kidney disease.
🔬 Role of Biomarkers
Biomarkers help detect organ damage and monitor disease progression.
Renal biomarkers studied:
-
NGAL
-
KIM-1
-
L-FABP
-
Cystatin C
Cardiac biomarkers studied:
-
BNP and NT-proBNP
-
Galectin-3
-
FGF-23
-
Endothelin-1
-
VEGF-A
-
Apoptosis-inducing factor (AIF)
📊 Key Findings
The study included 39 patients with Type IV cardiorenal syndrome and 31 healthy controls.
Results showed significantly elevated levels of both renal and cardiac biomarkers in patients. Strong correlations were observed between kidney injury markers and cardiac stress markers.
For example:
-
KIM-1 and L-FABP showed strong correlations with BNP and NT-proBNP
-
Renal markers were also associated with endothelin-1, FGF-23, galectin-3, and VEGF-A
These findings demonstrate a strong biological connection between kidney damage and cardiac dysfunction.
🩺 Clinical Significance
The study highlights the importance of integrated biomarker assessment in patients with cardiorenal syndrome. Monitoring both cardiac and renal markers may help clinicians:
-
Detect disease progression earlier
-
Improve risk assessment
-
Guide personalized treatment strategies
Understanding the heart–kidney interaction is essential for improving outcomes in patients with chronic kidney disease and heart failure.
👨⚕️ About the
Speaker
Dr. Almammadov
Fazil Choban is a nephrologist and PhD in
Medical Sciences. He graduated from Azerbaijan
Medical University and Astrakhan
State Medical Academy, where he completed internship training in surgery.
He has undertaken advanced professional training in
chronic kidney disease and dialysis management in Azerbaijan and Moscow. Over
the course of his career, he has served as Head of Hemodialysis Department and
hospital chief physician.
Since 2017, he has been Director of Narimanov
Medical Center. His scientific work focuses on dialysis-related hemodynamic
disorders and cardiorenal syndrome, and he has authored more than twenty
scientific publications along with a methodological manual.
Be part of the evolving science redefining
cardiogenic shock management.
#CVS2026 #Cardiology
#CardiovascularScience #HeartHealth #ClinicalCardiology #PreventiveCardiology
#MedicalResearch #HealthcareInnovation #GlobalHealth #MedicalConference
#VirtualConference #HeartCare #CardioResearch
No comments:
Post a Comment